Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan

• by Masashi Kasai, Satoshi Nakano, Shota Koide, Shogo Otake, Meiwa Shibata, Kasumi Ishida-Kuroki, Yo Sugawara, Yukihiro Akeda, Kandai Nozu, Motoyuki Sugai

• October 9, 2025

Case Report: Sequential leadless pacing after battery depletion in a patient with recurrent device-related infection

• by Assel Chinybayeva, Gaziza Marat, Zhanasyl Suleymen, Ayan Abdrakhmanov

• July 21, 2026

Tea saponin–soybean oil submicron emulsion promotes durable protective immunity against Pasteurella multocida

• by Xuemei Cui, Le Yu, Ruiting Zhang, Yee Huang, Zizhe Hu, Xiaoyu Li, Quanan Ji, Tuanyuan Shi, Guolian Bao, Yan Liu

• July 20, 2026

Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial

An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.

• by Teraya Smith

• July 23, 2026

• 3 min